n-butyl cyanoacrylate
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2017 (NCT04876976)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
C=C(C#N)C(=O)OCCCC- Mol. weight
- 153.18 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2104251 ↗
Also known as
- butyl 2-cyanoacrylate
- butyl 2-cyanoacrylate
- butyl alpha-cyanoacrylate
- butyl cyanoacrylate
- enbucrilate
- enbucrilate
- enbucrilate
- enbucrilate
- enbucrilate
- histacryl blue
- n-butyl 2-cyanoacrylate
- n-butyl-2-cyanoacrylate
- n-butyl-2-cyanoacrylate
- n-butyl cyanoacrylate
- n-butyl cyanoacrylate
- n-butyl cyanoacrylate
- n-butyl cyanoacrylate
- n-butyl cyanoacrylate
- n-butyl cyanoacrylate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06742983 | N/A | Aug 4, 2023 | Suez Canal University |
| NCT04403503 | N/A | Jul 1, 2018 | Hacettepe University |
| NCT04876976 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2017 | Ain Shams University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ain Shams University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Hacettepe University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Suez Canal University | Academic/Hospital | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1